In the past decade, extracellular vesicles (EVs) have been recognized as potent vehicles of
intercellular communication, both in prokaryotes and eukaryotes. This is due to their capacity …

Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different
cell types and participate in physiological and pathophysiological processes. EVs mediate …

the Asahara at al10 article, human CD34 expressing cells (15.7% enriched for CD34
expression) in adult peripheral blood were interrogated as putative EPCs via in vitro and in …

Induced pluripotent stem cells (iPSCs) may represent an ideal cell source for future
regenerative therapies. A critical issue concerning the clinical use of patient-specific iPSCs …

• Introduction• The proof‐of‐concept in vivo: the cell, the read‐out and the animal model‐The
CEPC: Still a putative cell‐Do CEPCs play an essential role in vascular (patho) physiology …

CD34 is a cell surface antigen expressed in numerous stem/progenitor cells including
hematopoietic stem cells (HSCs) and endothelial progenitor cells (EPCs), which are known …

Progenitor cells for the endothelial lineage have been widely investigated for more than a
decade, but continue to be controversial since no unique identifying marker has yet been …

Background The term endothelial progenitor cells (EPCs) is currently used to refer to cell
populations which are quite dissimilar in terms of biological properties. This study provides a …

Endothelial progenitor cells (EPCs) are currently being studied as candidate cell sources for
revascularization strategies. Despite these promising results, widespread clinical …